Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation

Paiva, Bruno; Vidriales, Maria-Belén; Cerveró, Jorge; Mateo, Gema; J. Pérez, Jose; A. Montalbán, Maria; Sureda, Anna; Montejano, Laura; C. Gutiérrez, Norma; García de Coca, Alfonso; de las Heras, Natalia; V. Mateos, Maria; C. López-Berges, Maria; García-Boyero, Raimundo; Galende, Josefina; Hernández, Jose; Palomera, Luis; Carrera, Dolores; Martínez, Rafael; de la Rubia, Javier; Martín, Alejandro; Bladé, Joan; J. Lahuerta, Juan; Orfao, Alberto; F. San Miguel, Jesús

doi:10.1182/blood-2008-05-159624

Public

Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation

Shared by NobleBlocks on Nov 15, 2008 • 12:00 AM UTC

Authors:

Bruno Paiva

Maria-Belén Vidriales

Jorge Cerveró

Abstract

Abstract Minimal residual disease (MRD) assessment is standard in many hematologic malignancies but is considered investigational in multiple myeloma (MM). We report a prospective analysis of the prognostic importance of MRD detection by multiparameter flow cytometry (MFC) in 295 newly diagnosed MM ...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!